Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01252212 · ClinicalTrials.gov registry record · Phase 3
Adherence, Improvement Measure (AIM) System
A Phase 3 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 3
- Development phase
- 99
- Enrollment target
NCT01252212 is a Phase 3 study that has completed, run by University of California, San Francisco. The registered enrollment target is 99 participants.
The verdict
NCT01252212, a Phase 3 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 99 participants
- Enrollment target
Study Summary
In this project, we will work directly with underserved patients in a safety-net setting to conduct a randomized clinical trial of standard-of-care adherence counseling versus a novel adherence intervention embedded in an existing PHR that uses cellular phone short message service (SMS) reminders and patient responses to the reminders. We will compare adherence rates in both arms as assessed by antiretroviral medication concentrations in hair samples and self-report; clinical outcomes will also be compared in the two arms. The project will examine medication adherence for antiretroviral medications and treatments of common conditions such as depression, hypertension, diabetes and hypercholesterolemia.
Interventions
- BEHAVIORAL SMS medication adherence
- BEHAVIORAL No SMS adherence reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01252212
The ClinicalTrials.gov registry entry for NCT01252212 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SMS medication adherence is the first listed.
NCT01252212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01252212 about?
NCT01252212 is a clinical study titled "Adherence, Improvement Measure (AIM) System". In this project, we will work directly with underserved patients in a safety-net setting to conduct a randomized clinical trial of standard-of-care adherence counseling versus a novel adherence intervention embedded in an existing PHR that uses cellular phone short message service (SMS) reminders an...
What is the current status of trial NCT01252212?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 99 participants. The study started on 2010-08. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01252212?
The interventions under investigation include: SMS medication adherence (BEHAVIORAL), No SMS adherence reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT01252212?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.